New recommendations developed from evidence-based research have been added to AORN’s Guideline for Care and Cleaning of Surgical Instruments. Several of these changes will have an impact on the quality of processing in sterile processing (SP) areas. This latest version, released on October 12, 2020, includes industry changes that have…
Before COVID-19 emerged as the biggest disruptor of 2020, many ambulatory surgery centers (ASCs) had been growing volume and receiving Medicare reimbursements for an increasing number of procedures. Stopping elective procedures in the spring was a significant setback, especially for smaller, independent facilities, notes a Global Healthcare Advisors (GHA) brief,…
Editor's Note The number of children’s mental health emergency department (ED) visits decreased sharply from mid-March through early April 2020, coincident with the implementation of community mitigation measures enacted to prevent COVID-19 transmission, and then visits increased steadily through October, this study from the Centers for Disease Control and Prevention…
Editor's Note Moderna Inc (Cambridge, Massachusetts) on November 16 announced that its vaccine is 94.5% effective at preventing COVID-19. Their analysis of a 30,000-person trial (half received the vaccine and half received a placebo) finds that 90 of the 95 COVID-19 documented cases are in the placebo group. The Moderna announcement…
Editor's Note The Joint Commission announced November 11 that it has modified its Environment of Care (EC) survey process for ambulatory surgery centers (those deemed and/or assigned life safety code surveyors), critical access hospitals, and hospitals, effective January 1, 2021. The change eliminates the 1-hour, sit-down discussion with members of…
Editor's Note The Centers for Medicare and Medicaid Services (CMS) on November 10 announced that Medicare will cover out-of-pocket costs for monoclonal antibody drugs for COVID-19 during the public health emergency. The agency’s coverage includes Eli Lilly’s bamlanivimab, which recently received an emergency use authorization from the Food and Drug…
Editor's Note The Food and Drug Administration (FDA) on November 6 issued an emergency use authorization (EUA) for the first serology test (GenScript USA Inc) to identify patients with neutralizing antibodies after a COVID-19 infection. Neutralizing antibodies have reduced the infection of cells in the laboratory, but their effects in…
Editor's Note Pfizer and BioNTech announced November 9 that their COVID-19 vaccine is more than 90% effective 7 days after the second dose in preventing COVID-19 infection in participants without evidence of prior infection. This means that protection is achieved 28 days after initiation of the vaccination, which consists of…
Editor's Note The Centers for Medicare and Medicaid Services (CMS) on November 5 released a set of toolkits and enrollment actions to take to administer the COVID-19 vaccine when it’s available. Many Medicare-enrolled providers don’t have to take any actions until the vaccine is available. Some Medicare-enrolled providers must also…
Editor's Note In this analysis of COVID-19 data from the Centers for Disease Control and Prevention, the proportion of preterm live births in women with COVID-19 infection during pregnancy was higher than that in the general population in 2019, suggesting that pregnant women with COVID-19 infection might be at risk…